Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection, Nancy G. Klimas, A. J. Rodger, Z. Fox, J. D. Lundgren, L. H. Kuller, C. Boesecke, D. Gey, A. Skoutelis, M. B. Goetz, A. N. Phillips, INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
Faculty Articles

Collaborators Interruption of antiretroviral therapy is associated with increased plasma cystatin, Nancy G. Klimas, A. Mocroff, C. Wyatt, L. Szczech, J. Neuhaus, W. El-Sadr, R. Tracy, L. Kuller, M. Shlipak, B. Angus, H. Klinker, M. Ross, INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
Faculty Articles

Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen, Nancy G. Klimas, Z. Fox, A. Phillips, C. Cohen, J. Neuhaus, J. Baxter, S. Emery, B. Hirschel, K. H. Hullsiek, C. Stephan, J. Lundgren, INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
Faculty Articles

Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial, Nancy G. Klimas, W. Burman, B. Grund, J. Neuhaus, J. Douglas Jr., G. Friedland, E. Telzak, R. Colebunders, N. Paton, M. Fisher, C. Rietmeijer, INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
Faculty Articles